Auvelity’s Early Alzheimer’s Agitation Launch Draws Bullish Analyst Notes

Mizuho, Needham and Guggenheim cite 32–34% script growth and robust 65+ uptake as Auvelity’s Alzheimer’s agitation launch gets off to a strong start.